Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
1
Bearish filings
25
Named actors
18
Disclosed $ (bull / bear)
$63.4M / $846.4M + 9 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-27 | Director Morris Arlene | sold | $119K | SEC ↗ |
| 2026-08-27 | Director Morris Arlene | sold | $1.6M | SEC ↗ |
| 2026-08-27 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) ARLENE MORRIS | filed notice to sell | $1.7M | SEC ↗ |
| 2026-08-10 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-07-30 | Chief Financial Officer John Green | adopted a selling plan | — | SEC ↗ |
1 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-07-30 |
| Chief Legal Officer Evan Kearns |
| adopted a selling plan |
| — |
| SEC ↗ |
| 2026-07-30 | Chief Medical Officer Dr. Jessica Sachs | adopted a selling plan | — | SEC ↗ |
| 2026-07-30 | President and Chief Executive Officer Andrew Robbins | adopted a selling plan | — | SEC ↗ |
| 2026-06-25 | member of our Board of Directors Dr. Karen Ferrante | adopted a selling plan | — | SEC ↗ |
| 2026-05-28 | member of our Board of Directors Arlene Morris | adopted a selling plan | — | SEC ↗ |
| 2026-05-19 | President and CEO Robbins Andrew R | gifted | — | SEC ↗ |
| 2026-03-31 | Director Fairmount Funds Management LLC | sold | $242.6M | SEC ↗ |
| 2026-03-31 | Director (via Goldman Sachs & Co. LLC) Fairmount Healthcare Fund II L.P. | filed notice to sell | $242.6M | SEC ↗ |
| 2026-03-31 | Institution (13F) Duquesne Family Office LLC | exited a position | $78.7M | — |
| 2026-01-22 | Director (via Jefferies LLC) Fairmount Healthcare Fund II L.P. | filed notice to sell | $127.4M | SEC ↗ |
| 2026-01-22 | Director Fairmount Funds Management LLC | sold | $127.4M | SEC ↗ |
| 2025-12-31 | Institution (13F) Duquesne Family Office LLC | added to a position | $63.4M | — |
| 2025-12-29 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) EVAN D KEARNS | filed notice to sell | $2.5M | SEC ↗ |
| 2025-12-29 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JOHN GREEN | filed notice to sell | $3.0M | SEC ↗ |
| 2025-12-29 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JOHN ROBINSON | filed notice to sell | $3.5M | SEC ↗ |
| 2025-12-29 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JESSICA SACHS | filed notice to sell | $3.2M | SEC ↗ |
| 2025-12-26 | Chief Scientific Officer Robinson John Edward | sold | $3.5M | SEC ↗ |
| 2025-12-26 | Chief Medical Officer Sachs Jessica | sold | $3.2M | SEC ↗ |
| 2025-12-26 | Chief Financial Officer Green John L. | sold | $3.0M | SEC ↗ |
| 2025-12-26 | Chief Legal Officer Kearns Evan | sold | $2.5M | SEC ↗ |